Impact of the (18)F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 Patients

Optimal HCC therapeutic management relies on accurate tumor staging. Our aim was to assess the impact of (18)F-FDG-WB-PET/MRI on HCC metastatic staging, compared with the standard of care CT-CAP/liver MRI combination, in patients with HCC referred on a curative intent or before transarterial radioem...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermersch, Mathilde, Mulé, Sébastien, Chalaye, Julia, Galletto Pregliasco, Athena, Emsen, Berivan, Amaddeo, Giuliana, Monnet, Aurélien, Stemmer, Alto, Baranes, Laurence, Laurent, Alexis, Leroy, Vincent, Itti, Emmanuel, Luciani, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432497/
https://www.ncbi.nlm.nih.gov/pubmed/34501465
http://dx.doi.org/10.3390/jcm10174017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432497/
https://www.ncbi.nlm.nih.gov/pubmed/34501465
http://dx.doi.org/10.3390/jcm10174017

Ejemplares similares